BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

632 related articles for article (PubMed ID: 21841316)

  • 1. Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity.
    Mamessier E; Sylvain A; Thibult ML; Houvenaeghel G; Jacquemier J; Castellano R; Gonçalves A; André P; Romagné F; Thibault G; Viens P; Birnbaum D; Bertucci F; Moretta A; Olive D
    J Clin Invest; 2011 Sep; 121(9):3609-22. PubMed ID: 21841316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human breast tumor cells induce self-tolerance mechanisms to avoid NKG2D-mediated and DNAM-mediated NK cell recognition.
    Mamessier E; Sylvain A; Bertucci F; Castellano R; Finetti P; Houvenaeghel G; Charaffe-Jaufret E; Birnbaum D; Moretta A; Olive D
    Cancer Res; 2011 Nov; 71(21):6621-32. PubMed ID: 21937679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peripheral blood NK cells from breast cancer patients are tumor-induced composite subsets.
    Mamessier E; Pradel LC; Thibult ML; Drevet C; Zouine A; Jacquemier J; Houvenaeghel G; Bertucci F; Birnbaum D; Olive D
    J Immunol; 2013 Mar; 190(5):2424-36. PubMed ID: 23359508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HER2-specific immunoligands engaging NKp30 or NKp80 trigger NK-cell-mediated lysis of tumor cells and enhance antibody-dependent cell-mediated cytotoxicity.
    Peipp M; Derer S; Lohse S; Staudinger M; Klausz K; Valerius T; Gramatzki M; Kellner C
    Oncotarget; 2015 Oct; 6(31):32075-88. PubMed ID: 26392331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer cell subsets and receptor expression in peripheral blood mononuclear cells of a healthy Korean population: Reference range, influence of age and sex, and correlation between NK cell receptors and cytotoxicity.
    Phan MT; Chun S; Kim SH; Ali AK; Lee SH; Kim S; Kim SH; Cho D
    Hum Immunol; 2017 Feb; 78(2):103-112. PubMed ID: 27884732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The TGF-β/SMAD pathway is an important mechanism for NK cell immune evasion in childhood B-acute lymphoblastic leukemia.
    Rouce RH; Shaim H; Sekine T; Weber G; Ballard B; Ku S; Barese C; Murali V; Wu MF; Liu H; Shpall EJ; Bollard CM; Rabin KR; Rezvani K
    Leukemia; 2016 Apr; 30(4):800-11. PubMed ID: 26621337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fc-optimized NKG2D-Fc constructs induce NK cell antibody-dependent cellular cytotoxicity against breast cancer cells independently of HER2/neu expression status.
    Raab S; Steinbacher J; Schmiedel BJ; Kousis PC; Steinle A; Jung G; Grosse-Hovest L; Salih HR
    J Immunol; 2014 Oct; 193(8):4261-72. PubMed ID: 25217158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inherent and Tumor-Driven Immune Tolerance in the Prostate Microenvironment Impairs Natural Killer Cell Antitumor Activity.
    Pasero C; Gravis G; Guerin M; Granjeaud S; Thomassin-Piana J; Rocchi P; Paciencia-Gros M; Poizat F; Bentobji M; Azario-Cheillan F; Walz J; Salem N; Brunelle S; Moretta A; Olive D
    Cancer Res; 2016 Apr; 76(8):2153-65. PubMed ID: 27197252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SDF-1α Reduces Human Natural Killer Cell Cytotoxicity against Chronic Myelogenous Leukemia K562 Cells.
    Mardomi A; Hossein-Nataj H; Jafari N; Mohammadi N; Abediankenari S
    Iran J Allergy Asthma Immunol; 2019 Oct; 18(5):493-500. PubMed ID: 32245293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melanoma cells inhibit natural killer cell function by modulating the expression of activating receptors and cytolytic activity.
    Pietra G; Manzini C; Rivara S; Vitale M; Cantoni C; Petretto A; Balsamo M; Conte R; Benelli R; Minghelli S; Solari N; Gualco M; Queirolo P; Moretta L; Mingari MC
    Cancer Res; 2012 Mar; 72(6):1407-15. PubMed ID: 22258454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Podocalyxin-like protein 1 functions as an immunomodulatory molecule in breast cancer cells.
    Amo L; Tamayo-Orbegozo E; Maruri N; Buqué A; Solaun M; Riñón M; Arrieta A; Larrucea S
    Cancer Lett; 2015 Nov; 368(1):26-35. PubMed ID: 26276714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of self-ligands for activating natural killer cell receptors.
    Lam RA; Chwee JY; Le Bert N; Sauer M; Pogge von Strandmann E; Gasser S
    Ann Med; 2013 Jun; 45(4):384-94. PubMed ID: 23701136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of CD158 and NKG2A Inhibitory Receptors and Underexpression of NKG2D and NKp46 Activating Receptors on NK Cells in Acute Myeloid Leukemia.
    Sandoval-Borrego D; Moreno-Lafont MC; Vazquez-Sanchez EA; Gutierrez-Hoya A; López-Santiago R; Montiel-Cervantes LA; Ramírez-Saldaña M; Vela-Ojeda J
    Arch Med Res; 2016 Jan; 47(1):55-64. PubMed ID: 26876298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short-term IL-2 activation.
    Vacca P; Martini S; Garelli V; Passalacqua G; Moretta L; Mingari MC
    Eur J Immunol; 2013 Feb; 43(2):550-61. PubMed ID: 23192659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An IL-15 superagonist/IL-15Rα fusion complex protects and rescues NK cell-cytotoxic function from TGF-β1-mediated immunosuppression.
    Fujii R; Jochems C; Tritsch SR; Wong HC; Schlom J; Hodge JW
    Cancer Immunol Immunother; 2018 Apr; 67(4):675-689. PubMed ID: 29392336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevation of MMP-9 and IDO induced by pancreatic cancer cells mediates natural killer cell dysfunction.
    Peng YP; Zhang JJ; Liang WB; Tu M; Lu ZP; Wei JS; Jiang KR; Gao WT; Wu JL; Xu ZK; Miao Y; Zhu Y
    BMC Cancer; 2014 Oct; 14():738. PubMed ID: 25274283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-2-driven regulation of NK cell receptors with regard to the distribution of CD16+ and CD16- subpopulations and in vivo influence after haploidentical NK cell infusion.
    Huenecke S; Zimmermann SY; Kloess S; Esser R; Brinkmann A; Tramsen L; Koenig M; Erben S; Seidl C; Tonn T; Eggert A; Schramm A; Bader P; Klingebiel T; Lehrnbecher T; Passweg JR; Soerensen J; Schwabe D; Koehl U
    J Immunother; 2010; 33(2):200-10. PubMed ID: 20145545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TGFβ drives NK cell metabolic dysfunction in human metastatic breast cancer.
    Slattery K; Woods E; Zaiatz-Bittencourt V; Marks S; Chew S; Conroy M; Goggin C; MacEochagain C; Kennedy J; Lucas S; Finlay DK; Gardiner CM
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33568351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decitabine has a biphasic effect on natural killer cell viability, phenotype, and function under proliferative conditions.
    Kopp LM; Ray A; Denman CJ; Senyukov VS; Somanchi SS; Zhu S; Lee DA
    Mol Immunol; 2013 Jul; 54(3-4):296-301. PubMed ID: 23328088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered NKp30, NKp46, NKG2D, and DNAM-1 Expression on Circulating NK Cells Is Associated with Tumor Progression in Human Gastric Cancer.
    Han B; Mao FY; Zhao YL; Lv YP; Teng YS; Duan M; Chen W; Cheng P; Wang TT; Liang ZY; Zhang JY; Liu YG; Guo G; Zou QM; Zhuang Y; Peng LS
    J Immunol Res; 2018; 2018():6248590. PubMed ID: 30255106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.